Cargando…
In Vivo Chemical Screening for Modulators of Hematopoiesis and Hematological Diseases
In vivo chemical screening is a broadly applicable approach not only for dissecting genetic pathways governing hematopoiesis and hematological diseases, but also for finding critical components in those pathways that may be pharmacologically modulated. Both high-throughput chemical screening and fac...
Autores principales: | Zhang, Yiyun, Yeh, J.-R. Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385708/ https://www.ncbi.nlm.nih.gov/pubmed/22778745 http://dx.doi.org/10.1155/2012/851674 |
Ejemplares similares
-
Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016) -
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022) -
CircRNAs in hematopoiesis and hematological malignancies
por: Bonizzato, A, et al.
Publicado: (2016) -
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies
por: Zhang, Hengwei, et al.
Publicado: (2023) -
EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)